Literature DB >> 7097947

Prevention of rubella transmission in medical facilities.

W L Greaves, W A Orenstein, H C Stetler, S R Preblud, A R Hinman, K J Bart.   

Abstract

The widespread use of rubella vaccine in the United States has dramatically decreased the number of rubella cases and has prevented epidemics. Nevertheless, outbreaks of rubella continue to occur in medical facilities and have become important in the transmission of the disease. Control of outbreaks requires isolation of infectious patients, assignment of immune staff only to infectious patients, exclusion from work of infectious personnel, special follow-up of pregnant women and exposed persons, and the rapid vaccination of susceptible staff. Implementation of hospital rubella prevention programs is preferable to controlling an outbreak. The vaccination of all susceptible personnel provides the opportunity for preventing rubella outbreaks, disruption of hospital services, and fetal rubella infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097947

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Nosocomial varicella: worth preventing, but how?

Authors:  S R Preblud
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

2.  Identification and immunization of medical students susceptible to measles and rubella: a nationwide survey.

Authors:  D L Murray; M R Weatherly; J L Sperling; L J Farquhar
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

Review 3.  Immunization policies in Canadian medical schools.

Authors:  M S Rowan; A O Carter; V J Walker
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

Review 4.  Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.

Authors:  Megan K Young; Allan W Cripps; Graeme R Nimmo; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

5.  Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome.

Authors:  Mihaela Lazar; Ludmila Perelygina; Roosecelis Martines; Patricia Greer; Christopher D Paddock; Gheorghe Peltecu; Emilia Lupulescu; Joseph Icenogle; Sherif R Zaki
Journal:  EBioMedicine       Date:  2015-11-27       Impact factor: 8.143

6.  Facilities for Centralized Isolation and Quarantine for the Observation and Treatment of Patients with COVID-19: Experience from Wuhan, China.

Authors:  Xianliang Wang; Jiao Wang; Jin Shen; John S Ji; Lijun Pan; Hang Liu; Kangfeng Zhao; Li Li; Bo Ying; Lin Fan; Liubo Zhang; Lin Wang; Xiaoming Shi
Journal:  Engineering (Beijing)       Date:  2021-04-22       Impact factor: 7.553

7.  Three cases of congenital rubella syndrome in the postelimination era--Maryland, Alabama, and Illinois, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-29       Impact factor: 17.586

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.